LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
118,779,098
Share change
-1,219,502
Total reported value
$220,940,693
Put/Call ratio
47%
Price per share
$1.86
Number of holders
82
Value change
-$2,430,736
Number of buys
33
Number of sells
47

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2022

As of 30 Jun 2022 LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) had 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 118,779,098 shares of stock of the company.
Largest 10 holders included Artal Group S.A., BVF INC/IL, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, D. E. Shaw & Co., Inc., NEA Management Company, LLC, PINNACLE ASSOCIATES LTD, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 82 institutional shareholders of the security as of 30 Jun 2022.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.